Vitro Diagnostics (VODG) Stock Price, News & Analysis

Company Overview

Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research, drug discovery, and clinical trials in the United States. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products for the treatment of diseases, such as heart disease, arthritis, multiple sclerosis, brain injury, autism, stroke, Parkinson's, and Alzheimer's diseases. The company also offers Tools for Stem Cell and Drug Discovery that provide researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives; media for growth and differentiation of stem cells; and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers MSC-Gro, a cell culture media product; MSC cell line for the treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, etc.; and testing and therapies related to endogenous stem cell activation. Further, the company provides diagnostic testing of stem cell activation and determination of stem cell functional status; and cell-based assays for discovery of novel stem cell activation agents and drugs for the treatment of osteoporosis. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.

Key Stats

• Today's Range: $0.40 to $0.40
• 50-Day Range: $0.40 to $0.40
• 52-Week Range: $0.13 to $1.04
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VODG Stock Analysis - Frequently Asked Questions

How have VODG shares performed this year?

Vitro Diagnostics' stock was trading at $0.40 on January 1st, 2025. Since then, VODG shares have increased by 0.0% and is now trading at $0.40.

How do I buy shares of Vitro Diagnostics?

Shares of VODG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vitro Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vitro Diagnostics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), American Battery Technology (ABML), Biogen (BIIB), Devon Energy (DVN), Heatwurx (PCSA) and Akero Therapeutics (AKRO).

Company Calendar

• Today: 7/19/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:VODG
• CIK: 793171
• Web: www.vitrobiopharma.com
• Phone: 303-999-2130
• Fax: 469-633-0088
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.21)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.87 million
• Net Margins: -356.89%
• Pretax Margin: -356.95%
• Return on Equity: N/A
• Return on Assets: -107.24%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.04
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: $1.86 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A